FDA Clearance Tracker · P210006-S018
Thoraflex Hybrid
Last checked: Nov 20, 2026Latest source record: Sep 8, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Sep 8, 2026
Approved
Time to decision
180 days
Received Mar 12, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P210006-S018
- Device name
- Thoraflex Hybrid
- Applicant
- Vascutek, Ltd.
- Applicant location
- Inchinnan
- Received
- Mar 12, 2026
- Decided
- Sep 8, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P210006
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for new branch configurations of the Thoraflex Hybrid device
Source documents
Other decisions for Vascutek, Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K241550 · Decided Feb 27, 2025 · 272 days after receipt
Device type: Prosthesis, Vascular Graft, Of 6mm And Greater Diameter (DSY) · Cardiology
6 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.